Each year, The Leukemia & Lymphoma Society of Canada forms a group of medical experts with the task of reviewing research projects taking place in Canada that show the greatest promise in advancing our understanding of different blood cancers, ability to test therapies and ultimately, to find cures. Once a year, our Scientific Review Panel selects research projects led by established and new scientists working in various cancer centres across Canada.
Canadian clinician scientists are invited to submit proposals to The Leukemia & Lymphoma Society of Canada’s Clinician Scientist Fellow Award grant program offered in partnership with the Canadian Institutes of Health Research (CIHR).
The intent of the Clinician Scientist Fellow Award is to encourage early-stage specialist clinicians to pursue a career in blood cancer research. The award is specifically targeted at MDs near, or recently at, the completion of specialty training in hematology, oncology, hematopathology, pathology, or other related disciplines and who have initiated or have immediate plans to begin supervised research training directed at blood cancers.
This opportunity is designed to foster through provision of a contribution to their salary and research program the acquisition of skills and independence to conduct research in blood cancers at the laboratory, clinical or combined levels.
Applicants are welcome to contact LLSC to determine their eligibility to apply.
The Clinician Scientist Fellow Award is for a maximum of 3 years, depending on eligibility. The maximum award per year is $100 000 ($60,000 salary contribution and $40,000 research allowance). By providing funding in the early stages of their career, it is believed that scientists will be able to maintain focus on their research and therefore be able to make great advances in our understanding of blood cancers.
2020 Grant Competition
Opens Nov 1, 2019
The application process will occur in two phases. The first phase is submission and consideration of a Letter of Intent (LOI). The second phase is the invitation for and submission of a Full Application. The applicant must register with the LLSC Research Portal, Proposal Central in order to apply. Both the LOI and the Full Application must be submitted electronically to the LLSC Research Portal, with an Abbreviated application to be submitted to CIHR through ResearchNet (details to come)
Applicants must carefully read the program guidelines before beginning their applications.
- Download – LLSC-CIHR 2020 Clinician Scientist Fellow Award Guidelines & Instructions
- Download – LLSC-CIHR 2020 Clinician Scientist Fellow Award Policies and Procedures
2019-2020 Application Key Dates
|Call for Proposals||November 1, 2019|
|Letter of Intent (LOI) Due||January 8, 2020 3 p.m. (EST)|
|Notification of Full Application Invite||January 2020|
|Full application deadline||February 19 , 2020, 3 pm EST|
|Review Panel Meeting||April 2020|
|Notification of Awards||May 2020|
|Award Start Date||July 2020|
Funds for competitive applications will be awarded on the basis of scientific merit, using a priority rating system.
Submitting a Letter of Intent is mandatory for all applicants
In partnership with: